Outsourcing in Clinical Trials West Coast 2023
Arena International are delighted to announce Outsourcing in Clinical Trials West Coast will be returning to Burlingame!
For the 15th Annual event, our flagship clinical show will focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed.
At the 2022 event, Day 1 began with an expert panel debating how long will we feel the ripples of the pandemic; we enjoyed a Keynote presentation from the FDA on their response and lessons learned post-COVID-19. The program consisted of multiple practical sessions and fireside chats, including one on regenerative medicine as a future trend, and one on how to keep your patient at the heart of your trial design.
The Technology track kicked off with Uber Health discussing how we can remove transport as a barrier of care; as well as a debate on Decentralized and Hybrid Trials from our industry experts.
On the Patient Engagement stream attendees had the opportunity to debate how best to include patient voices in clinical trials and what is best approach to recruitment.
The previous Speaking Faculty included The FDA, Genentech, Ultragenyx, Iovance Biotherapeutics, Ascendis Pharma, Acceleron Pharma, Uber Health and many more.
Don’t miss out; join us in Burlingame on March 1st & 2nd 2023. We can't wait to see you there!
What to expect this year?
This is a great opportunity to network and share knowledge with region’s leading pharmaceutical firms, biotechs and med device companies, discuss operationally efficient, specifically targeted clinical trials.
The 2023 program boasts 4 full streams jam packed with content;
- – Clinical Operations & Outsourcing
- – Technology & Innovation
- – Patient Engagement
- – Medical Device Trials
Dan Solis, MHADWCI Program Division Director, Division of West Coast Import (DWCI) Office of Enforcement and Import Operations
U.S. Food and Drug Administration
Jennifer LeeSenior Vice President of Clinical Operation, Biostats, and Data Management
Lisa LeaDirector, Global Patient Engagement and Advocacy
Acceleron Pharma Inc., a wholly-owned subsidiary of Merck & Co., Inc.
As a global leader in business services for over 20 years, TransPerfect is a woman-owned, privately held company with over 90 offices globally on six continents. Since its inception, TransPerfect has been supporting life sciences in the conduct of global clinical development, commercialization and life cycle management of products catering to the health care community.
Advanced Clinical is a global clinical research services organization, providing CRO, FSP, Strategic Resourcing and Consulting Services for biopharmaceutical and medical device organizations. Our company is committed to improving all lives touched by clinical research and we address the hopes of patients and healthcare professionals with industry-leading services and technology in life sciences. Visit our website to learn more about how we deliver a Better Clinical Experience.
With over 40 years’ experience, 600 beds and locations in NA, EU and Asia, Celerion conducts First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and NDA-enabling clinical pharmacology research. Celerion provides full study services including statistics, data management and biostatistics (including PK/PD analysis), and bioanalytical services.
MedPoint Digital develops intuitive, ICH-GCP compliant eClinical platforms for virtual investigator meetings, trial portals, interactive modules, and virtual clinical trials. Our digital solutions enable sites to be more productive, with online study training, study eBinders (eISF), digital study alerts and SUSARs, patient visit guides, and a wide range of study tools, available via web portals and mobile apps.
Philips BioTel Research is an industry leader in medical imaging and cardiovascular safety testing for clinical trials.
Philips BioTel Research offers global operational support for cardiovascular monitoring in all therapeutic areas, and advances imaging services in oncology, cardiovascular, metabolic, musculoskeletal, neurologic, and medical device studies. Their experienced research team comprises key opinion leaders, board-certified cardiologists and radiologists, sub-specialty scientists, and highly trained technicians – who acquire, evaluate, and report high-quality data through an efficient, cloud-based infrastructure. Many biopharmaceutical trial sponsors rely on or scientific leaders to help design and optimize their protocols and statistical analysis plans. We have conducted clinical trials contributing to the market approval of nearly 100 new drugs to date.
Translational Drug Development (TD2) is a world-class oncology drug development organization specializing in the development of new oncology medicines. TD2 offers fully integrated precision oncology clinical development solutions that combine the highest standards in clinical trials management, disruptive imaging, biomarker strategies, and unparalleled access to real-time patient data.
We identify and invite individuals we believe to be the best speakers in the market, if you think you can make a difference to the quality of our events please contact the programme director of the event:
T: +44 (0) 207 936 6822